Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
14.10
+0.32 (2.32%)
At close: Oct 8, 2025, 4:00 PM EDT
14.10
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:04 PM EDT
Benitec Biopharma Stock Forecast
Stock Price Forecast
The 5 analysts that cover Benitec Biopharma stock have a consensus rating of "Strong Buy" and an average price target of $24.8, which forecasts a 75.89% increase in the stock price over the next year. The lowest target is $17 and the highest is $30.
Price Target: $24.8 (+75.89%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Benitec Biopharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 5 | 5 | 5 | 5 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $20 | Buy | Reiterates | $20 | +41.84% | Sep 24, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $35 → $29 | Buy | Maintains | $35 → $29 | +105.67% | Sep 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +98.58% | May 19, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $20 | Buy | Reiterates | $20 | +41.84% | May 15, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $18 → $20 | Buy | Maintains | $18 → $20 | +41.84% | Apr 10, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.72
from -1.05
EPS Next Year
-1.86
from -1.72
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -1.06 | -0.23 |
| Avg | -1.72 | -1.86 |
| Low | -3.82 | -3.90 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.